BioNano Genomics
Presencia
BioNano Genomics es una empresa que cotiza bajo el símbolo de cotización BNGO (US).
Ejecutivos
Ver el organigrama con sus 28 ejecutivos principales
Biografías más buscadas en BioNano Genomics
- Erik Holmlin, Director, President and Chief Executive Officer
- Kristiina Vuori, Director
- David Barker, Chairman of the Board
Recientes movimientos de ejecutivos en BioNano Genomics
- Christopher Stewart, Chief Financial Officer, se jubilará en sept.. de 2023 (noticia publicada el 15 de agosto de 2023).
- Gülsen Kama, se ha incorporado a la empresa como Chief Financial Officer (noticia publicada el 15 de agosto de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en BioNano Genomics.
Biotecnología
BioNano Genomics tiene 2.284 competidores entre los que se incluyen Lonza (Suiza), Eurofins (Luxemburgo) y Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnología
- Karius acaba de anunciar una recaudación de fondos de 100 millones de dólares. (publicado el 3 de mayo de 2024).
- Transcarent acaba de anunciar una recaudación de fondos de 126 millones de dólares. (publicado el 2 de mayo de 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (publicado el 2 de mayo de 2024).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
Redes sociales sobre BioNano Genomics
- BioNano Genomics en Wikipedia, Google News y Yahoo Finance
- BioNano Genomics en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Erik Holmlin 
Llame a BioNano Genomics al +1 858...
